Aura Biosciences to Repurchase 6.92M Shares from Matrix at $5.64

Aura Biosciences, Inc. has entered into an agreement to repurchase up to 6,922,870 shares of its common stock from Matrix Capital Management Master Fund, LP. This repurchase, representing approximately 10.8% of outstanding shares, will occur at a price of $5.64 per share. The transaction is contingent upon the closing of a separate underwritten equity offering, with funding sourced from net proceeds exceeding $200 million from that offering. The company's Audit Committee and Board of Directors have approved the repurchase.